And now a word from our sponsor - Bashturd, Inc. Let's

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
613
And now a word from our sponsor - Bashturd, Inc.

Let's not lose sight of this. Bashturds (BTs) work for their overlords who want to acquire shares in Bioelectronics, ticker symbol BIEL, on the OTC. The OTC being that place where they can get away w/ it w/ a minimum of backlash. THEY pick a message board that has the same standard and away they go.

BTs do what they do, as odious as it is, b/c the overlords, who do not wish to get THEIR hands dirty saying awful things on all things BIEL, want shares in a company THEY feel, for one reason or another (skirting the edge of insider info, perhaps?), this company will pay THEM a rich reward; i.e. - the potential is highly lucrative. BTs don't bash bad companies. Or companies on the downswing w/ little potential value. When?, don't know, thus the repetitive nature of the ongoing, daily, unwavering, not-to-creative bashing of BIEL.

An up-and-coming company, which is what we are, is perfect. Simply b/c BIEL has its' hands full juggling a full basket of NDAs, negotiations, regulations, policies, politics, funding, approvals, product development, corporate strategy, governmental agencies, etc. on a limited budget; and "on-the-clock" and "under-the-gun". No pressure. Everything is on the fly in the sense that they are expanding such as they have never done before. Lots of questions, decisions have to be made, schedules have to be set and, of course, what to do when the perfect plan hits a snag. Every company goes thru this, no exception. No time to chase BTs or pursue legal remedies.

Some things Biel has a part to play, others not so much, like Synergy. They have a signed contract and the pending order is contingent on getting approvals in a few countries. That is Synergy's work, not ours. So we wait. Some 'investors', esp'ly BTs, take full advantage.

Is Viant/Meraqi on board??? Big question for me. I can't see any scenario requiring BIEL to deliver 100,000s (millions?) of devices worldwide w/o having a full-fledged contractual manufacturing relationship w/ them. Dealing w/ the lag time on containers ocean bound is not a viable option - ref: Politics. For me, the Sree Koneru connection is too strong and a little too coincidental. Developing, coordinating, and managing that situation alone would require significant time, energy, and resources.

Or here in our own backyard dealing w/ CMMS, insurance, and/or DOD; or any number of alphabet agencies. Getting CPT codes or the equivalent elsewhere is nothing short of an eternity in bureaucratic hell. Dealing w/ govt'al red tape requires the patience of Job and heaven help you should you drop a comma or use too many staples or whatever. Flying near blind is par for the course. My nephew's employer leases property to the US gov't and he swears every time he turns around 2 pcs of paper magically transforms into 17 overnite. Silly wabbits.

And the twitter campaign is ongoing. They are pushing hard on that. The budget is tight, for now. If that campaign was not having a positive effect, I think CEO Kelly would pull the plug in a heartbeat. She hasn't and the ads are becoming more hardhitting and direct. Somebody is reading them. These targeted adverts are like a magnifying glass. First the smoke (interest), then the fire (new business). Our target audience is large, deep-pocketed, and highly incentivized to make changes. RecoveryRx to the rescue.

So, we wait. It's frustrating. I feel it as we all do. I want an update and feel like one is due but really I have no idea. Oddly enough, the creepy crawly BTs continue to bash and, for now anyway, this is a good (sort of?) thing. Never thought I'd catch myself admitting that! I need to take a shower.

"Sic parvis magma" - Greatness from small beginnings
Do yourself a favor ... BUY_MORE_SHARES

Later, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 102

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 94

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
Doximity Faces Legal Heat: 23% Stock Plunge Analyzed

Updated Category News Views 12

Doximity's Rollercoaster: Steep Drop Amid Lawsuits Imagine watching your portfolio take a gut-wrenching plunge—and that's the rollercoaster ride Doximity investors experienced. On May 14, 2026, Doximity's stock nosedived by 23%, closing at $18.01 per share. This tumble, which marked a painful conclusion to a series of financial disappointments, has thrown the company...

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 0

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading
Royce Micro-Cap Trust: Navigating Small-Cap Waves

Updated Category News Views 42

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

Continue Reading
McKinsey and Parloa Join Forces on AI Customer Service

Updated Category News Views 66

AI-Revolutionizing Customer Service: The New Partnership Out of the boardroom and into the trenches, McKinsey joins hands with Parloa, aiming to reshape how enterprises handle customer service through artificial intelligence. Forget all the corporate fluff you've heard before; these guys are dead set on closing the massive gap companies face in deploying AI agents...

Continue Reading
BlueNord Signals Strategic Shift with Vår Energi Merger

Updated Category News Views 47

BlueNord's Bold Move in the Energy Sector With the ink barely dry on their third-quarter results, BlueNord has dropped a bombshell: a merger approved with Vår Energi. This isn't just another page in their corporate books—it's a strategic pivot that could redefine their place within the oil and gas arena. Anybody keeping an eye on the energy sector right now should sit...

Continue Reading
BetaNXT and Pave Finance Transform Wealth Management

Updated Category News Views 52

AI Takes Center Stage in Wealth Management You know, it's not every day we see two powerhouses like BetaNXT and Pave Finance buddying up to shake up the financial advisory world. This partnership's all about harnessing AI to give wealth management firms and financial advisors some serious firepower in portfolio planning. BetaNXT, already a big name with its slick...

Continue Reading
Storyteq's AI Edge Earns Gartner Leader Status Again

Updated Category News Views 69

Pioneering AI in Digital Asset Management Alright, folks, this ain't just another tech release to gloss over with your morning coffee—ITG's Storyteq has snagged the 'Leader' title in Gartner's Magic Quadrant for Digital Asset Management. It's no small feat to earn such recognition three years running, and the secret sauce is their advanced AI capabilities. A Unified AI...

Continue Reading

Top 5 Most Recently Viewed Articles

Rgenta Therapeutics Presents Innovative Data on RGT-61159

Updated Category News Views 192

Rgenta Therapeutics Unveils Preclinical Data on RGT-61159 WOBURN, Mass. – Rgenta Therapeutics, a pioneering biotechnology firm focused on the development of small molecule drugs targeting RNA for cancer and neurological disorders, has made an exciting announcement regarding its lead program, RGT-61159. This promising small molecule inhibitor, which selectively targets...

Continue Reading
TriMas Packaging Showcases Innovations at Upcoming Trade Events

Updated Category News Views 122

TriMas Packaging's Participation in Major Trade Shows TriMas Packaging, a leading group under TriMas (NASDAQ: TRS), is thrilled to announce its involvement in two prominent trade exhibitions. At these events, the company will display its extensive range of innovative and eco-friendly dispensing and closure product solutions that have garnered attention in the industry....

Continue Reading
Understanding Apollo Global Management's Recent Market Trends

Updated Category News Views 109

Understanding Apollo Global Management's Recent Market Trends The market is currently witnessing a notable shift in investor sentiment towards Apollo Global Management (NYSE: APO). This trend is not only striking but worth examining closely for anyone interested in market movements. Recent tracking of options activity has highlighted an interesting wave of bullish...

Continue Reading
Capricor Faces Securities Fraud Lawsuit: Investor Action Key

Updated Category News Views 16

Investors Take the Stage in Capricor Securities Case Here's something that'll make any shareholder's pulse quicken: Capricor Therapeutics, Inc. (NASDAQ: CAPR) is caught in a whirlwind of legal drama, and it's no soap opera. Rather, it's a class action lawsuit, brought forth by the vigilant folks over at Schall, Brown & Schwartz LLP ('SBS'), aimed squarely at alleged...

Continue Reading
Broad Arrow Auctions Collects $14.5 Million in Sales Triumph

Updated Category News Views 333

Broad Arrow Auctions Kicks Off a Successful Year Broad Arrow Auctions, an esteemed arm of Hagerty, recently embarked on its 2025 auction calendar with a remarkable showcase—the Academy of Art University Collection Auction. Held at the university's museum facilities, this auction captured the attention of classic car enthusiasts and collectors alike. A Glance at the...

Continue Reading